SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management

Sponsor
University of Pennsylvania (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04714398
Collaborator
(none)
425
1
3
17.1
24.8

Study Details

Study Description

Brief Summary

A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Opt-In Recruitment
  • Behavioral: Opt-Out Recruitment
N/A

Detailed Description

The investigators will utilize the Way to Health (WTH) platform to develop and evaluate a new remote monitoring enrollment model that is integrated with routine clinical care at Penn Family Care (PFC), an academic family medicine practice in West Philadelphia. Among patients with poorly controlled HTN the investigators will:

  1. Compare the effect of sending eligible patients a blood pressure cuff with the mailed invitation letter and opt-out framing versus the more conventional method of phone calls following mailed letters.

  2. Evaluate the feasibility and effectiveness of a remote monitoring program with individualized stepped escalation for hypertension management.

Study Design

Study Type:
Interventional
Actual Enrollment :
425 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
SupportBP 2.0: Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management
Actual Study Start Date :
Feb 26, 2021
Actual Primary Completion Date :
Mar 21, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Opt-In Recruitment

All recruitment messaging will be framed for patients as they must opt-in to participate in the remote monitoring program.

Behavioral: Opt-In Recruitment
Patients in the opt-in recruitment arm will receive a letter describing the program and inviting them to participate in the remote monitoring program. Along with the letter they will receive an informational brochure and a copy of the informed consent form. Patients in this arm will then receive a recruitment phone call explaining the program and consenting the participant verbally. If the participant consents to participate in the remote monitoring program, to receive text messaging, and to connection to care, the research coordinator will mail a blood pressure cuff and begin the remote monitoring program for the patient 6 days later.

Experimental: Opt-Out

All recruitment messaging will be framed as though participation is the default, and patients must opt-out of participating in the remote monitoring program.

Behavioral: Opt-Out Recruitment
Patients assigned to opt-out recruitment will receive a blood pressure cuff with instructions in the mail along with a letter describing the program and opt-out framing regarding their participation, as well as a brochure and a copy of the informed consent form. Patients in this arm will receive a recruitment phone call similar to recruitment arm A, explaining the program and consenting the participant verbally. If the participant consents to participate in the remote monitoring program, to receive text messaging, and to connection to care, the research coordinator will begin the remote monitoring program for the patient immediately.

No Intervention: Usual Care

Patients in the usual care arm will not be contacted by study staff, they will not receive a blood pressure cuff, and they will not be asked to participate in any component of the blood pressure monitoring program.

Outcome Measures

Primary Outcome Measures

  1. Proportion Participating by Recruitment Method [6 months, from date of consent to end of remote monitoring program]

    The proportion of patients participating in each study arm out of the number randomized to that study arm.

Secondary Outcome Measures

  1. Proportion Engaged by Recruitment Method [6 months, from date of consent to end of remote monitoring period]

    The proportion of patients recruited by each method who are actively engaged with the program

  2. Proportion with Controlled Blood Pressure by Monitoring vs. Usual Care [6 months, from date of consent to end of remote monitoring program]

    The proportion with controlled blood pressure by remote monitoring and the proportion with controlled blood pressure by clinic visits (usual care).

  3. Blood Pressure Trajectory by Recruitment Method [6 months, from date of consent to end of remote monitoring program]

    The systolic and diastolic blood pressure trajectory by recruitment arm.

  4. Proportion of BP Measurements Submitted by Recruitment Method [6 months, from date of consent to end of remote monitoring program]

    The proportion of requested BP measurements submitted by each patient by recruitment arm

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Between 18 and 75 years old with HTN (ICD-10 code I10)

  2. Has had at least one office visit at Penn Family Care (PFC) within the past 12 months (at time of chart review), with the last visit having a BP reading exceeding HTN guidelines (150/90 if >60 or, 140/90 if ages 21-59 yrs or has CKD or diabetes).

  3. Must have a cellular phone with texting capabilities

  4. Must be prescribed at least one medication for hypertension

Exclusion Criteria:
  1. Has metastatic (Stage IV) cancer

  2. Has end stage renal disease

  3. Has congestive heart failure

  4. Has dementia

  5. BMI >= 50

  6. Is Non-English speaking requiring a translator

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

  • Principal Investigator: Shivan Mehta, MD, MBA, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shivan J Mehta, Principal Investigator, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04714398
Other Study ID Numbers:
  • 844150
First Posted:
Jan 19, 2021
Last Update Posted:
May 17, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shivan J Mehta, Principal Investigator, University of Pennsylvania
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2022